MDCX

Medicus Pharma Ltd.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$1.72

Price (1 Year)

$110 $1.72

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %60 / %30
Non-compliant assets / Total market cap %33.5 / %30
Non-compliant revenue / Total incomeNo data

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin.

Website

Analysis (Turkish): MDCX Hissesi Caiz mi, Helal mi? Medicus Pharma Ltd. Katılım Analizi